Showing 7181-7190 of 20410 results for "".
The Slippery Slope of Overt Hepatic Encephalopathy
https://reachmd.com/programs/cme/The-Slippery-Slope-of-Overt-Hepatic-Encephalopathy/39789/Explore diagnostic and treatment challenges in patients with hepatic encephalopathy to improve outcomes for your patients.Treatment of Hepatic Encephalopathy: When, What, How, and Why?
https://reachmd.com/programs/cme/Treatment-of-Hepatic-Encephalopathy-When-What-How-and-Why/39790/Explore diagnostic and treatment challenges in patients with hepatic encephalopathy to improve outcomes for your patients.Understanding the Role of the Alternate Complement Pathway in PNH
https://reachmd.com/programs/project-oncology/understanding-the-role-of-the-alternate-complement-pathway-in-pnh/48875/How does the alternate complement pathway apply in the PNH treatment landscape? Tune in to learn more about its role.VICTOR Trial Results: Vericiguat Efficacy and Safety Across Baseline Background Therapy in Contemporary Ambulatory Patients With HFrEF
https://reachmd.com/clinical-practice/cardiology/victor-trial-results-vericiguat-efficacy-and-safety-across-baseline-background-therapy-in-contemporary-ambulatory-patients-with-hfref/39253/VICTOR Trial Results: Vericiguat Efficacy and Safety Across Baseline Background Therapy in Contemporary Ambulatory Patients With HFrEFVICTOR Trial Results: Regional Variation in Outcomes and Response to Vericiguat in Patients With HFrEF
https://reachmd.com/clinical-practice/cardiology/victor-trial-results-regional-variation-in-outcomes-and-response-to-vericiguat-in-patients-with-hfref/39249/VICTOR Trial Results: Regional Variation in Outcomes and Response to Vericiguat in Patients With HFrEFRedefining HF Care: The Role of Finerenone in Patients With LVEF ≥40%
https://reachmd.com/clinical-practice/cardiology/redefining-hf-care-the-role-of-finerenone-in-patients-with-lvef-40/36521/Redefining HF Care: The Role of Finerenone in Patients With LVEF ≥40%Case-Based AUD Challenge
https://reachmd.com/programs/cme/case-based-aud-challenge/15220/The burden of AUD is often drowned out by the growing opioid epidemic, but AUD impacts many of our patients. Tune in to find out how you can help.Ramping Up to Manage COVID-19 Patients
https://reachmd.com/programs/covid-19-frontlines/ramping-up-to-manage-covid-19-patients/11527/Every COVID-19 care team has unique issues based on their situation, which is why collaboration and communication is key.We CAN Fix Healthcare: The Future is NOW
https://reachmd.com/programs/book-club/we-can-fix-healthcare-future-now/8491/Dr. Stephen Klasko, President and CEO of Jefferson University, discusses ways to improve the American healthcare system.Turning Flares Into Function: Flag Uncontrolled Disease
https://reachmd.com/programs/cme/turning-flares-into-function-flag-uncontrolled-disease/54770/Explore treat-to-target strategies and FcRn inhibitor use to guide outcomes-driven management of generalized myasthenia gravis.